Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia [7]

International Journal of Dermatology

Volumn 45, Issue 10, 2006, Pages 1249-1251

  Kuwano, Yoshihiro ^a   Asahina, Akihiko ^a   Watanabe, Rei ^a   Fujimoto, Manabu ^a   Ihn, Hironobu ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; ALPHA INTERFERON; CORTICOSTEROID; IMATINIB;

AGED; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DERMATOMYOSITIS; DISEASE EXACERBATION; DOSE CALCULATION; DRUG ERUPTION; EOSINOPHILIA; ERYTHEMA; EYELID EDEMA; HUMAN; HUMAN TISSUE; LETTER; LYMPHOCYTIC INFILTRATION; MALE; PERIORBITAL EDEMA; SKIN BIOPSY; SKIN EDEMA;

AGED; ANTINEOPLASTIC AGENTS; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; EXANTHEMA; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; PIPERAZINES; PYRIMIDINES;

EID: 33749864590     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02930.x     Document Type: Letter

References (10)

1. Kantarjian H, Sawyers C, Hochhaus A, et al. Hematologic and cytogenetic responses to Imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346: 645-652.
2. Kanda T, Ohashi M, Makino S, et al. A successful case of oral molecularly targeted therapy with imatinib for peritoneal metstasis of a gastrointestinal stromal tumor. Int J Clin Oncol 2003; 8: 180-183.
3. Raspollini MR, Villanucci A, Amunni G, et al. C-kit expression in uterine leiomyosarcomas: An immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus. J Chemotherapy 2003; 2: 103-108.
4. Tsao AS, Kantarjian H, Cortes J, et al. Imatinib mesylate causes hypopigmentation in the skin. Cancer 2003; 98: 2483-2487.
5. Esmaeli B, Prieto VG, Butler CE, et al. Severe periorbital edema secondary to STI571 (Gleevec). Cancer 2002; 95: 881-887.
6. Milojkovic D, Short K, Salisbury JR, et al. Dose-limiting dermatological toxicity secondary to imatinib mesylate (STI571) in chronic myeloid leukaemia. Leukemia 2003; 17: 1414-1416.
7. Brouard MC, Prins C, Mach-Pascual S, et al. Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia. Dermatology 2001; 203: 57-59.
8. Brouard M, Saurat JH. Cutaneous reactions to STI571. N Engl J Med 2001; 345: 618-619.
9. Callen JP. Dermatomyositis. Lancet 2000; 355: 53-57.
10. Tierney LMJ, Jensen B, Schwartz RA. Dermatomyositis associated with chronic myelogenous leukemia. Dermatologica 1985; 171: 189-192.